Merck Co
- All
- News
- Web Stories
-
US Health Advisers Back Pfizer, Merck Pneumonia Shots For Adults Over 50
A key panel of US health advisers voted in favor of lowering the age recommendation for vaccines made by Pfizer Inc and Merck & Co that protect against pneumococcal disease, clearing a path for wider use.
-
Pfizer, Merck Pneumonia Shots Approved For Adults Over 50
A key panel of US health advisers voted in favor of lowering the age recommendation for vaccines made by Pfizer Inc. and Merck & Co. that protect against pneumococcal disease, clearing a path for wider use.
-
Merck's Covid Pill Shows Lower Efficacy In Updated Data
Merck & Co said updated results showed its Covid-19 pill reduced the risk of hospitalization or death among adults with mild to moderate disease by 30%, less than a previous estimate and well below a rival treatment from Pfizer Inc.
-
Hyderabad Firm Seeks Approval To Produce Generic Merck Covid Pill
The bulk drugs manufacturer Optimus Pharma is seeking domestic regulatory approval to produce a generic version of Merck & Co's oral COVID-19 treatment molnupiravir, the company's top executive told Reuters on Thursday.
-
Gates Foundation To Spend $120 Million To Speed Access To Generics Of Merck Covid Pill
The Bill & Melinda Gates Foundation said on Wednesday it would spend up to $120 million to kick-start development of generic versions of Merck & Co's oral COVID-19 treatment to help ensure lower-income countries have equal access to the drug.
-
WHO Aims To Help Poorer Countries Access Vaccine With $10 Covid Pills
A World Health Organization-led programme to ensure poorer countries get fair access to COVID-19 vaccines, tests and treatments aim to secure antiviral drugs for patients with mild symptoms for as little as $10 per course.
-
Merck COVID-19 Pill Has Vital Indian Link, Maker Sees Stock Price Jump
India's Everest Organics Ltd said on Tuesday it had started making the active pharmaceutical ingredient (API) for a generic version of Merck & Co's experimental antiviral drug molnupiravir to treat mild to moderate COVID-19.
-
2 Indian Firms Seek To End Current Trials Of Merck's Anti-Covid Pill
Two drugmakers in the country have requested permission to end their late-stage trials on Merck & Co's experimental antiviral drug molnupiravir in moderate COVID-19 patients.
-
Australia To Buy Merck's COVID-19 Pill As Cases Hit Record In Major Cities
Australia will buy 300,000 courses of Merck & Co's experimental antiviral pill, Prime Minister Scott Morrison said on Tuesday, as Victoria logged the highest number of daily COVID-19 infections of any state in the country since the pandemic began.
-
Thailand In Talks With Merck For 200,000 Courses Of New Covid Pill
Thailand's government is in talks with U.S. drugmaker Merck & Co to purchase 200,000 courses of the company's experimental antiviral pill for COVID-19 treatment, a Thai official said on Monday.
-
Five Indian Drugmakers To Jointly Start Trial Of Merck & Co's Covid Drug
Fivegeneric drugmakers, including Cipla and Dr Reddy's Laboratories, said on Tuesday they would jointly conduct a clinical trial of Merck & Co's anti-viral drug to treat mild COVID-19 in non-hospitalised patients in the country.
-
Merck Taps 5 Indian Drugmakers To Expand Covid Drug Production
Merck & Co Inc said on Tuesday it had partnered with five Indian generic drugmakers, including Cipla Ltd and Sun Pharmaceutical Industries Ltd, to expand production and access to its experimental COVID-19 drug.
-
3 CEOs Resign From Trump Council Over Charlottesville Violence
The chief executives of Intel Corp, Merck & Co Inc and Under Armour Inc resigned from US President Donald Trump's American Manufacturing Council on Monday, following Trump's initially tepid response to weekend violence at a rally of white supremacists in Charlottesville, Virginia.
-
Merck CEO Resigns From Trump Council Over Charlottesville
Merck & Co Inc Chief Executive Kenneth Frazier resigned from U.S. President Donald Trump's American Manufacturing Council on Monday, saying he was taking a stand against intolerance and extremism.
-
'New Day' In Lung Cancer As Merck Drug Shines, Works With Chemo
Merck & Co scored a double hit on Sunday with new clinical data showing its Keytruda immunotherapy offered big benefits in previously untreated lung cancer patients, either when given on its own or with chemotherapy.
-
US Health Advisers Back Pfizer, Merck Pneumonia Shots For Adults Over 50
A key panel of US health advisers voted in favor of lowering the age recommendation for vaccines made by Pfizer Inc and Merck & Co that protect against pneumococcal disease, clearing a path for wider use.
-
Pfizer, Merck Pneumonia Shots Approved For Adults Over 50
A key panel of US health advisers voted in favor of lowering the age recommendation for vaccines made by Pfizer Inc. and Merck & Co. that protect against pneumococcal disease, clearing a path for wider use.
-
Merck's Covid Pill Shows Lower Efficacy In Updated Data
Merck & Co said updated results showed its Covid-19 pill reduced the risk of hospitalization or death among adults with mild to moderate disease by 30%, less than a previous estimate and well below a rival treatment from Pfizer Inc.
-
Hyderabad Firm Seeks Approval To Produce Generic Merck Covid Pill
The bulk drugs manufacturer Optimus Pharma is seeking domestic regulatory approval to produce a generic version of Merck & Co's oral COVID-19 treatment molnupiravir, the company's top executive told Reuters on Thursday.
-
Gates Foundation To Spend $120 Million To Speed Access To Generics Of Merck Covid Pill
The Bill & Melinda Gates Foundation said on Wednesday it would spend up to $120 million to kick-start development of generic versions of Merck & Co's oral COVID-19 treatment to help ensure lower-income countries have equal access to the drug.
-
WHO Aims To Help Poorer Countries Access Vaccine With $10 Covid Pills
A World Health Organization-led programme to ensure poorer countries get fair access to COVID-19 vaccines, tests and treatments aim to secure antiviral drugs for patients with mild symptoms for as little as $10 per course.
-
Merck COVID-19 Pill Has Vital Indian Link, Maker Sees Stock Price Jump
India's Everest Organics Ltd said on Tuesday it had started making the active pharmaceutical ingredient (API) for a generic version of Merck & Co's experimental antiviral drug molnupiravir to treat mild to moderate COVID-19.
-
2 Indian Firms Seek To End Current Trials Of Merck's Anti-Covid Pill
Two drugmakers in the country have requested permission to end their late-stage trials on Merck & Co's experimental antiviral drug molnupiravir in moderate COVID-19 patients.
-
Australia To Buy Merck's COVID-19 Pill As Cases Hit Record In Major Cities
Australia will buy 300,000 courses of Merck & Co's experimental antiviral pill, Prime Minister Scott Morrison said on Tuesday, as Victoria logged the highest number of daily COVID-19 infections of any state in the country since the pandemic began.
-
Thailand In Talks With Merck For 200,000 Courses Of New Covid Pill
Thailand's government is in talks with U.S. drugmaker Merck & Co to purchase 200,000 courses of the company's experimental antiviral pill for COVID-19 treatment, a Thai official said on Monday.
-
Five Indian Drugmakers To Jointly Start Trial Of Merck & Co's Covid Drug
Fivegeneric drugmakers, including Cipla and Dr Reddy's Laboratories, said on Tuesday they would jointly conduct a clinical trial of Merck & Co's anti-viral drug to treat mild COVID-19 in non-hospitalised patients in the country.
-
Merck Taps 5 Indian Drugmakers To Expand Covid Drug Production
Merck & Co Inc said on Tuesday it had partnered with five Indian generic drugmakers, including Cipla Ltd and Sun Pharmaceutical Industries Ltd, to expand production and access to its experimental COVID-19 drug.
-
3 CEOs Resign From Trump Council Over Charlottesville Violence
The chief executives of Intel Corp, Merck & Co Inc and Under Armour Inc resigned from US President Donald Trump's American Manufacturing Council on Monday, following Trump's initially tepid response to weekend violence at a rally of white supremacists in Charlottesville, Virginia.
-
Merck CEO Resigns From Trump Council Over Charlottesville
Merck & Co Inc Chief Executive Kenneth Frazier resigned from U.S. President Donald Trump's American Manufacturing Council on Monday, saying he was taking a stand against intolerance and extremism.
-
'New Day' In Lung Cancer As Merck Drug Shines, Works With Chemo
Merck & Co scored a double hit on Sunday with new clinical data showing its Keytruda immunotherapy offered big benefits in previously untreated lung cancer patients, either when given on its own or with chemotherapy.
